Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.

BMC Genomics · 2017 · PMC5688496 · PMID 29143667

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The OFF-score showed an increasing trend during rHuEpo administration and significantly increased throughout the post phase (Holm-Bonferroni adjusted p < 0.05) (Fig. 3 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.